These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19444112)

  • 41. Nonalcoholic fatty liver disease (NAFLD) in children.
    Sathya P; Martin S; Alvarez F
    Curr Opin Pediatr; 2002 Oct; 14(5):593-600. PubMed ID: 12352254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
    Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
    Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic fatty liver disease in children.
    Mager DR; Roberts EA
    Clin Liver Dis; 2006 Feb; 10(1):109-31, vi-vii. PubMed ID: 16376797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
    Byrne CD
    Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?
    Roberts EA
    J Hepatol; 2007 Jun; 46(6):1133-42. PubMed ID: 17445934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.
    Huang HL; Lin WY; Lee LT; Wang HH; Lee WJ; Huang KC
    Obes Surg; 2007 Nov; 17(11):1457-63. PubMed ID: 18219772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals.
    Kim BJ; Kim NH; Kim BS; Kang JH
    Cardiology; 2012; 123(1):54-61. PubMed ID: 22986520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-alcoholic fatty liver disease and the metabolic syndrome: an update.
    Rector RS; Thyfault JP; Wei Y; Ibdah JA
    World J Gastroenterol; 2008 Jan; 14(2):185-92. PubMed ID: 18186553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonalcoholic fatty liver disease as a component of the metabolic syndrome.
    Khashab MA; Liangpunsakul S; Chalasani N
    Curr Gastroenterol Rep; 2008 Feb; 10(1):73-80. PubMed ID: 18417046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in pediatric nonalcoholic fatty liver disease.
    Loomba R; Sirlin CB; Schwimmer JB; Lavine JE
    Hepatology; 2009 Oct; 50(4):1282-93. PubMed ID: 19637286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome.
    Castro-Martínez MG; Banderas-Lares DZ; Ramírez-Martínez JC; Escobedo-de la Peña J
    Cir Cir; 2012; 80(2):128-33. PubMed ID: 22644007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance in nonalcoholic fatty liver disease.
    Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
    Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
    Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Nonalcoholic fatty liver disease].
    Ko JS
    Korean J Gastroenterol; 2010 Jul; 56(1):6-14. PubMed ID: 20664312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
    Reinehr T; Woelfle J; Wunsch R; Roth CL
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.
    Vajro P; Lenta S; Socha P; Dhawan A; McKiernan P; Baumann U; Durmaz O; Lacaille F; McLin V; Nobili V
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):700-13. PubMed ID: 22395188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.